Home » Topics » Regulatory » NMPA

NMPA
RSS

China FDA accepts fruquintinib NDA for advanced colorectal cancer

June 12, 2017

Tagrisso approved in China for NSCLC

March 27, 2017

WuXi-MedImmune cleared to conduct phase I studies of WBP-216 in China

Jan. 19, 2017

U.S. and China IND clearances for Ascentage's APG-1252

Dec. 28, 2016

CFDA grants approval for clinical trials of fadanafil

Dec. 16, 2016

CFDA accepts CStone Pharmaceuticals' IND for anti-PD-L1 monoclonal antibody

Oct. 21, 2016

BeiGene cleared to conduct clinical trials of BGB-A317 in China

Sep. 12, 2016

Chinese clinical trial authorization for TaiGen's furaprevir

Aug. 19, 2016

BioNano Genomics and Berry Genomics to codevelop next-generation mapping system

Aug. 18, 2016

Cervarix approved in China

July 18, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...